drugset / Trial / NCT02781519

Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans

NCT02781519

Phase 1 Recruiting 100 enrolled Yale University
RandomizedCrossoverQuadruple-blindBasic science

Summary

The purpose of the study is to characterize the acute effects of cannabinoids in women relative to men and to begin probing the mechanisms that may underlie gender differences.

Timeline

Start
2015-06
Primary completion
2026-06
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dronabinol Other / unclassified 0.015 mg/kg Intravenous

Indications

No indication recorded.